Daily Cosmetic Research Analysis
Key advances span cosmetic safety and efficacy: an expert mode-of-action framework argues six widely used organic sunscreen filters lack carcinogenic potential, a large multi-institutional cohort quantifies risks when combining cosmetic breast surgery with abdominoplasty, and two case reports suggest adult egg allergy may be induced by cosmetics containing ostrich egg yolk extract. Together they inform regulatory science, surgical decision-making, and product safety surveillance.
Summary
Key advances span cosmetic safety and efficacy: an expert mode-of-action framework argues six widely used organic sunscreen filters lack carcinogenic potential, a large multi-institutional cohort quantifies risks when combining cosmetic breast surgery with abdominoplasty, and two case reports suggest adult egg allergy may be induced by cosmetics containing ostrich egg yolk extract. Together they inform regulatory science, surgical decision-making, and product safety surveillance.
Research Themes
- Regulatory toxicology of cosmetic UV filters
- Safety of combined aesthetic surgical procedures
- Allergenic risks from animal-derived cosmetic ingredients
Selected Articles
1. Mode of action approach supports a lack of carcinogenic potential of six organic UV filters.
The authors propose and apply a mode-of-action framework to evaluate carcinogenic potential of six commonly used organic UV filters (avobenzone, ensulizole, homosalate, octinoxate, octisalate, octocrylene). Synthesizing mechanistic, exposure, and toxicology data, they argue rodent 2-year bioassays are often not human-predictive and conclude current evidence supports a lack of carcinogenic potential for these filters.
Impact: Addresses a high-profile regulatory question about sunscreen safety with a mechanistically grounded alternative to traditional rodent bioassays. May inform FDA decision-making and reassure public health messaging on sunscreen use.
Clinical Implications: Reinforces that sunscreens containing these filters can remain recommended for skin cancer prevention while additional data are considered. Encourages adoption of human-relevant MOA frameworks, potentially reducing unnecessary long-term animal studies.
Key Findings
- Proposes a mode-of-action (MOA) framework integrating exposure and mechanistic data to assess carcinogenic potential.
- For six organic UV filters (avobenzone, ensulizole, homosalate, octinoxate, octisalate, octocrylene), current evidence supports lack of carcinogenic potential in humans.
- Highlights poor human predictivity of traditional 2-year rodent carcinogenicity studies and offers an alternative supplemental approach aligned with FDA safety concerns over systemic absorption.
Methodological Strengths
- Mechanistic, exposure-driven assessment improves human relevance over default bioassays.
- Cross-chemical comparison across six commonly used filters enhances generalizability.
Limitations
- Narrative framework without new experimental carcinogenicity data.
- Conclusions depend on completeness and quality of existing toxicology datasets.
Future Directions: Prospective validation of the MOA framework with human-relevant in vitro/new approach methodologies and regulatory case studies; harmonization with international guidelines to replace or reduce 2-year rodent bioassays.
Ultraviolet (UV) filters, the active ingredients in sunscreens, have been used for several decades to reduce the risk of acute and chronic damage to the skin from solar UV radiation, which can lead to skin cancer. Based on recent clinical studies showing that certain UV filters are absorbed systemically at low levels in humans, the US Food and Drug Administration (FDA) has requested supplementing existing safety data with preclinical studies including oral and dermal 2-year rodent carcinogenicity studies. Although the conduct of 2-year rodent carcinogenicity studies has been the s
2. Safety of Combined Versus Isolated Cosmetic Breast Surgery and Abdominoplasty: Insights from a Multi-institutional Database.
In 7,865 NSQIP cases, combining cosmetic breast surgery with abdominoplasty increased reoperation risk versus abdominoplasty alone and increased overall and medical complications versus isolated breast surgery, while surgical complication rates were not elevated. Findings refine risk counseling for patients considering combined procedures.
Impact: Provides large-scale, contemporary, multi-institutional estimates of risk trade-offs for combined aesthetic procedures, directly informing shared decision-making and perioperative planning.
Clinical Implications: Use combined procedures judiciously with tailored counseling about higher reoperation and medical complication risks compared with isolated breast surgery. Optimize patient selection and medical optimization to mitigate risk.
Key Findings
- Combined abdominoplasty + cosmetic breast surgery was associated with higher reoperation risk versus abdominoplasty alone (OR 2.07; p=0.04).
- Compared with isolated cosmetic breast surgery, combined procedures had higher overall complications (OR 1.70; p=0.04) and medical complications (OR 5.30; p<0.0001).
- No significant differences in surgical complications in either comparison (e.g., vs abdominoplasty alone OR 0.72; p=0.26; vs breast surgery alone OR 0.85; p=0.73).
Methodological Strengths
- Large, multi-institutional dataset (ACS-NSQIP) with standardized outcome definitions.
- Adjusted analyses with odds ratios and hypothesis testing across procedure groups.
Limitations
- Retrospective observational design with potential selection and coding biases.
- Short-term outcomes; longer-term complications and aesthetic outcomes not captured.
Future Directions: Prospective registries capturing longer-term outcomes and patient-reported measures; risk stratification tools to guide selection for combined procedures.
INTRODUCTION: Abdominoplasty and breast surgery are popular cosmetic procedures, often performed as stand-alone or combined procedures. However, the safety of combining these surgeries remains poorly understood. METHODS: We analyzed data from the ACS-NSQIP database spanning 2008-2021, focusing on patients who underwent isolated cosmetic breast surgery, isolated cosmetic abdominoplasty, or the combination of both. We evaluated four primary outcomes: general complications (reoperation, readmission, mortality), surgical complications, medical complications, and overall complications (general + surgical + medical). Further analysis considered the specific type of cosmetic breast surgery. RESULTS: A total of 7865 female patients were identified, of whom 20.5% underwent isolated abdominoplasty, 65.3% cosmetic breast surgery, and 14.2% combined abdominoplasty with concurrent cosmetic breast surgery. Combined surgery was associated with a significantly higher risk of reoperations (OR 2.07; p = 0.04) compared to abdominoplasty alone. However, there was no significant difference in overall complications (OR 1.17; p = 0.40), surgical complications (OR 0.72; p = 0.26), or medical complications (OR 0.97; p = 0.91) between these two groups. Comparing combined to isolated cosmetic breast surgery, there was a higher risk of overall complications (OR 1.70; p = 0.04) and medical complications (OR 5.30; p < 0.0001) but no significant difference in general complications (OR 1.40; p = 0.33) or surgical complications (OR 0.85; p = 0.73). CONCLUSION: Combining breast surgery with abdominoplasty increases the risk of reoperations but does not elevate the risk of surgical or medical complications. However, patients seeking combined surgeries are more likely to experience adverse events than those seeking isolated cosmetic breast surgery. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
3. [TWO CASES OF ADULT EGG ALLERGY THAT DEVELOPED AFTER USING COSMETIC PRODUCTS CONTAINING OSTRICH EGG YOLK EXTRACT].
Two adult women developed IgE-mediated egg allergy after prolonged use of cosmetics containing ostrich egg yolk extract, with positive skin prick tests to egg and the cosmetics and positive basophil activation tests to the products. Findings suggest potential transcutaneous sensitization from animal-derived cosmetic ingredients.
Impact: Raises a tangible safety signal that cosmetic use may induce food allergy via skin exposure, with direct implications for ingredient selection, labeling, and post-market surveillance.
Clinical Implications: Advise patients with atopy or barrier dysfunction about potential sensitization from animal-derived cosmetic ingredients; consider reviewing product histories in new adult-onset food allergy cases and report suspected cases to regulatory bodies.
Key Findings
- Two adults using cosmetics with ostrich egg yolk extract developed immediate reactions after egg ingestion and had elevated egg yolk-specific IgE.
- Skin prick tests were positive to chicken egg white, egg yolk, and the used cosmetics; basophil activation tests were also positive for the cosmetics.
- No bird exposure history, supporting possible transcutaneous sensitization linked to cosmetic ingredient exposure (bird-egg syndrome-like).
Methodological Strengths
- Comprehensive allergy workup including skin prick testing and basophil activation tests.
- Temporal association with prolonged cosmetic use strengthens plausibility.
Limitations
- Two-case report cannot establish causality or estimate incidence.
- Lack of component-resolved diagnostics to identify specific allergenic epitopes within the extract.
Future Directions: Surveillance studies to quantify risk; component-resolved allergen characterization of ostrich egg yolk extracts; evaluation of labeling and reformulation strategies to mitigate sensitization.
Ostrich antibodies have a cost advantage over antibodies derived from small animals and are commercially used in diagnostic reagents. They are also expected to be effective in preventing infection, and products containing them, such as cosmetics, are available on the market. We encountered two cases of egg allergy in adult women after using cosmetics containing ostrich egg yolk extract to which this antibody was applied. Case 1: a 44-year-old woman who consumed Japanese pizza with semi-cooked eggs and experienced eyelid swelling, abdominal pain, vomiting, urticaria, and dyspnea. Case 2: a 21-year-old woman who ate "oyakodon" (a chicken and egg dish) containing raw egg yolk, resulting in a cough, hoarseness, itching and hypotension. They had used cosmetics containing ostrich egg yolk extract for approximately five years and one year, respectively. Both patients had elevated egg yolk-specific IgE antibody titers, consistent with bird-egg syndrome, but neither had a history of bird breeding. In both cases, the results of prick tests for chicken egg white, egg yolk and the cosmetics they used were positive, and the basophil activation tests of the same cosmetic products were also positive. From these results, we speculated that the use of cosmetics containing ostrich egg yolk extract is possibly associated with their development of an egg allergy.